Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Altria Group Inc (MO) vs Oscar Health Inc (OSCR) Price & Performance

Altria Group IncTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Oscar Health Inc — how do they compare? Altria Group Inc trades at $65.02 (market cap $114.13B), while Oscar Health Inc trades at $27.91 (market cap $8.54B). The key difference: Altria Group Inc is far larger — about 13.4× Oscar Health Inc's market cap, and Altria Group Inc pays a 6.2% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

MOOSCR
Market Cap
$114.13B$8.54B
Sector
Consumer StaplesHealth
52-Week High
$74.92$32.18
52-Week Low
$54.72$10.85
Enterprise Value
$136.34B$4.90B
Dividend Yield
6.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.

MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.

Oscar Health Inc

OSCR trades at $27.90, up 5.12% with strong recent earnings performance including Q2 2026 EPS beating estimates. The stock shows bearish technical signals but positive fundamental momentum with revenue growth from $11.7B to $15.3B and a swing to profitability. Recent news highlights record 2026 profitability and raised full-year guidance.

The outlook appears constructive with analyst consensus target of $32.50 offering 16% upside. Key risks include execution on growth targets and competitive pressures. The valuation remains attractive with P/S of 0.53, though investors should monitor Q3 earnings delivery against expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR